Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes AssociationRichard A. Insel, Anette‐G. Ziegler, Jessica L. Dunne et al.|Diabetes Care|2015Cited by 1.2k
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 DiabetesManuela Battaglia, Mark Peakman, Dorothy Becker et al.|Diabetes Care|2019Cited by 350
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 DiabetesTodd M. Brusko, Mark A. Atkinson, Clive Wasserfall et al.|Diabetes|2007Cited by 253
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune DiabetesAaron W. Michels, Maki Nakayama, Laurie G. Landry et al.|Diabetes|2016Cited by 197
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 DiabetesMichael J. Haller, W. J. Russell, Desmond Schatz et al.|Diabetes Care|2018Cited by 183